Cargando…

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Advanced therapy medical products (ATMPs) are rapidly growing as innovative medicines for the treatment of several diseases. Hence, the role of quality analytical tests to ensure consistent product safety and quality has become highly relevant. Several clinical trials involving dendritic cell (DC)-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pancisi, Elena, Granato, Anna Maria, Scarpi, Emanuela, Ridolfi, Laura, Carloni, Silvia, Moretti, Cinzia, Guidoboni, Massimo, De Rosa, Francesco, Pignatta, Sara, Piccinini, Claudia, Soldati, Valentina, Calabrò, Luana, Framarini, Massimo, Stefanelli, Monica, Bulgarelli, Jenny, Tazzari, Marcella, Fanini, Francesca, Petrini, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323699/ https://www.ncbi.nlm.nih.gov/pubmed/35891165 http://dx.doi.org/10.3390/vaccines10070999

Ejemplares similares

Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
por: Bulgarelli, Jenny, et al.
Publicado: (2019)

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
por: Ridolfi, Laura, et al.
Publicado: (2018)

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay
por: Carloni, Silvia, et al.
Publicado: (2021)

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
por: Ridolfi, Laura, et al.
Publicado: (2010)

Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”
por: Ridolfi, Laura, et al.
Publicado: (2011)

The Renewal of Cancer Immunotherapy
por: Bulgarelli, Jenny, et al.
Publicado: (2023)

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients
por: Ridolfi, Laura, et al.
Publicado: (2013)

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
por: de Rosa, Francesco, et al.
Publicado: (2014)

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
por: Bulgarelli, Jenny, et al.
Publicado: (2021)

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
por: Ridolfi, Laura, et al.
Publicado: (2014)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
por: Gurrieri, Lorena, et al.
Publicado: (2023)

Status of precision Monte Carlo tools for luminosity monitoring at meson factories
por: Balossini, G, et al.
Publicado: (2007)

Evaluation of in vivo labelled dendritic cell migration in cancer patients
por: Ridolfi, Ruggero, et al.
Publicado: (2004)

Health System Response to the 2023 Floods in Emilia-Romagna, Italy: A Field Report
por: Valente, Martina, et al.
Publicado: (2023)

Antimicrobial stewardship programs in Emilia-Romagna, Italy
por: Pan, A, et al.
Publicado: (2011)

Usutu Virus Persistence and West Nile Virus Inactivity in the Emilia-Romagna Region (Italy) in 2011
por: Calzolari, Mattia, et al.
Publicado: (2013)

Region Emilia Romagna: Primary Health Care Integration/Regione Emilia-Romagna: l’integrazione nel sistema di Cure Primarie
por: Basenghi, Maria
Publicado: (2012)

Female breast cancer subtypes in the Romagna Unit of the Emilia-Romagna cancer registry, and estimated incident cases by subtypes and age in Italy in 2020
por: Crocetti, Emanuele, et al.
Publicado: (2023)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
por: Ridolfi, Ruggero, et al.
Publicado: (2006)

Workplace physical aggressions in Italy and Emilia Romagna region
por: Zanardi, Francesca, et al.
Publicado: (2021)

Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy
por: Manfredini, Roberto, et al.
Publicado: (2010)

Emilia-Romagna Regional Blood System accreditation as an example of improvement through application of specific requirements: a retrospective analysis
por: Cortellazzi, Pilade, et al.
Publicado: (2021)

The Cost of Arbovirus Disease Prevention in Europe: Area-Wide Integrated Control of Tiger Mosquito, Aedes albopictus, in Emilia-Romagna, Northern Italy
por: Canali, Massimo, et al.
Publicado: (2017)

Increasing trends of Acinetobacter Baumannii infections in Emilia-Romagna, Italy
por: Gagliotti, C, et al.
Publicado: (2011)

Environmental Factors and Kawasaki Disease Onset in Emilia-Romagna, Italy
por: Corinaldesi, Elena, et al.
Publicado: (2020)

Immediate psychological effects of COVID-2019 in Emilia Romagna, Italy
por: Piretti, I., et al.
Publicado: (2021)

Sand Flies and Pathogens in the Lowlands of Emilia-Romagna (Northern Italy)
por: Calzolari, Mattia, et al.
Publicado: (2022)

Workshop on Heavy-Quark Factory and Nuclear Physics Facility with Superconducting Linacs
por: De Sanctis, E, et al.
Publicado: (1988)

Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
por: Arienti, Chiara, et al.
Publicado: (2011)

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation
por: Maio, Michele, et al.
Publicado: (2021)

Home Management of Children With COVID-19 in the Emilia-Romagna Region, Italy
por: Vergine, Gianluca, et al.
Publicado: (2020)

Interprofessional collaboration between different health care professions in Emilia Romagna
por: Carradore, Marco, et al.
Publicado: (2021)

Incidence of malignant mesothelioma and asbestos exposure in the Emilia-Romagna region, Italy
por: Mangone, Lucia, et al.
Publicado: (2022)

Full One-loop Electro-Weak Corrections to Three-jet Observables at the Z pole and Beyond
por: Calame, C M Carloni, et al.
Publicado: (2007)

An integrated response to the impact of coronavirus outbreak on the Emergency Medical Services of Emilia Romagna
por: Semeraro, Federico, et al.
Publicado: (2020)

Illegal fishing with electrofishing devices in the Po river basin, Emilia Romagna, Italy
por: Mazzariol, Sandro, et al.
Publicado: (2021)

Arbovirus Screening in Mosquitoes in Emilia-Romagna (Italy, 2021) and Isolation of Tahyna Virus
por: Calzolari, Mattia, et al.
Publicado: (2022)

Vertical integration and contractual network in the cardiovascular sector: the experience of the Italian region Emilia Romagna
por: Ugolini, Cristina, et al.
Publicado: (2003)

Experimental results on crossbreeding involving beef (Piedmont and Romagna) and dairy cattle (Friesian) in italy
por: Santoro, P
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_233rtciucr11nlfckpth4gsisf